Today: 3 July 2026
Browse Category

SWX:UBXN 6 June 2025

Everything You Never Knew You Needed to Know About Differential and Precise Point Positioning

Everything You Never Knew You Needed to Know About Differential and Precise Point Positioning

Global Navigation Satellite Systems like GPS have revolutionized how we find our position on Earth. Yet, the standard GPS accuracy often isn’t sufficient for missions like precision farming, engineering surveys, autonomous navigation, or tectonic measurements Esa. To bridge this accuracy gap, two advanced techniques have emerged over the years: Differential GNSS and Precise Point Positioning. These methods take basic GNSS to the next level, achieving sub-meter to centimeter-level accuracy by cleverly handling errors in satellite signals. In this comprehensive report, we’ll dive into what DGNSS and PPP are, how they work, their history and evolution, technical principles, comparisons of performance, real-world applications across industries, benefits and limitations, current technologies, case studies, and future developments. By the end, you’ll have a deep understanding of these high-precision positioning techniques – truly everything you never knew you needed to know about DGNSS and PPP. Differential GNSS is a technique to improve GNSS accuracy by using one or more stationary reference receivers to provide correction data to the user’s receiver. In a typical DGNSS setup, a base station at a known, surveyed location compares its GNSS-derived position to its true position and computes position errors or range corrections for each satellite signal Wikipedia Esa.

Stock Market Today

  • Guardant Health (GH) trades near fair value as Shield coverage expands
    July 3, 2026, 2:56 PM EDT. Guardant Health (GH) is up more than 350% in the past three years, lifted by new insurance coverage for its Shield test and FDA clearances for Guardant360 CDx. Even after the run, a DCF analysis puts the stock's value close to where it trades now. GH swaps at 20.6 times sales, well above other Healthcare stocks. Cash burn continues, with a free cash flow loss of $232.5 million, leaving dilution a risk. Some investors weigh the strong revenue drivers against that burn as GH sits at the top end of its valuation range.
Go toTop